HOME >> BIOLOGY >> NEWS
Report focuses on the role good microbes play in future medicine

Washington, DC June 7, 2006 Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders, according to a report released by the American Academy of Microbiology, Probiotic Microbes: The Scientific Basis.

"Theoretically, beneficial microorganisms could be used to treat a range of clinical conditions that have been linked to pathogens, including gastrointestinal problems like irritable bowel syndrome and inflammatory bowel disease, oral diseases like tooth decay and periodontal disease, and various other infections, including vaginal infections and possibly skin infections. Probiotics could also conceivably be put to use in preventing disease or thwarting autoimmune disorders. A number of these possibilities are being explored in research labs and hospitals around the world," says Richard Walker of the Food and Drug Administration, a co-chair of the steering committee that produced the report.

Probiotics can help prevent and treat disease through a number of mechanisms. One way is by interacting directly with the disease-causing microbes, making it harder for them to cause disease. An example of this is the ingestion of probiotic bacteria to prevent or treat diarrhea. The organisms help reinforce the natural bacterial barrier that exists on the lining of the digestive tract providing additional protection against pathogenic organisms that can cause diarrhea.

"Several probiotics have been shown to shorten the duration of acute watery diarrhea caused by rotavirus in children. Other causes of diarrhea may also be addressed through probiotics," says Carol Wells of the University of Minnesota, a member of the steering committee.

Another example of microbe-microbe interaction in probiotics is a phenomenon known as "competitive exclusion" in which beneficial microbes directl
'"/>

Contact: Angelo Bouselli
abouselli@asmusa.org
202-942-9292
American Society for Microbiology
8-Jun-2006


Page: 1 2

Related biology news :

1. Report recommends off-site disposal of secondary waste
2. SNM initiatives supported by inclusions in NAS Report on competitiveness of US chemistry research
3. AAAS/EurekAlert! refocus on China with 2007 Fellowships for Science Reporters in Developing Regions
4. Report calls for improved monoclonal antibodies against solid tumors
5. Report outlines funding to conserve half of Massachusettss land
6. Report challenges common ecological hypothesis about species abundance
7. Report highlights change in Canadas forests
8. Report: Canadas Yellowstone too small for wildlife
9. Report warns about carbon dioxide threats to marine life
10. Herringtons annual 2006 State of the Shore Report, May 22
11. Report finds cruise industry is protecting the precious places it visits

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Report focuses the role good microbes play future medicine

(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
(Date:5/21/2013)... Inflamax scientists worked closely with ... design the study, which will provide critical insight ... used in the study of allergy treatments, the ... (NAC) models. Although both the models are well ... no direct comparison between the allergic responses evoked ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: